Biovision's eyes

Let me talk about Biovision & Digital Health — February 27th 2017

Like Robert, I have had the privilege to be a part of Biovision for some time, and more specifically on the thematic of Digital Health in the past years. It is a fascinating field with many experts claiming the health sector is about to go through a profound transformation due to digitalization. More than a billion people still lack access to basic health care and the WHO estimated in 2013 that there was a global shortage of over 17 million healthcare workers, mostly in Africa and Southeast Asia. I confess that the aspect that has made me particularly passionate about digital health is how it will improve access to information and care in countries and areas where shortage of health infrastructure and health workers is particularly prevalent.

It is wonderful to see that Digital Health is becoming an increasingly important pillar of Biovision. In April, there will be a panel again on the Digital Patient as well as a workshop the day prior which will focus on the importance of impact evaluation. Moreover, Biovision is being held in conjunction to SIDO, a leading international event dedicated to the Internet of Things where 6.500 entrepreneurs, manufacturers, startups and technology actors will be present. The dual event will undoubtedly enrich the conversations around the impact of technology on health at Biovision this year.

Digital health includes subcategories such as mobile health (mHealth), health information technology (IT), wearable devices and sensors, telehealth and telemedicine. Very briefly, digital health can: reduce inefficiencies, improve access, reduce costs, increase quality, and make health care more personalized for patients.

Dr. Eric Topol, one of the foremost experts on Digital Health, says “Medicine is about to go through its biggest shakeup in history.” I could not agree with him more. In one of his recent books The Patient Will See You Now, he details how the mobile revolution will trigger a democratization of healthcare where patients take a bigger role in their own well-being. For example, a smartphone equipped with the right apps and connected to sensors can today eliminate many visits to the doctor’s. Digital monitors and sensors (which can also be put into your bloodstream) can collect health data on any physiological metric: heart rate, blood pressure, blood glucose, body temperature, sleep habits, eye pressure, brain waves and more.

To start off this short series of comments on digital health as we prepare for the next Biovision, and for those of you interested in finding out more here is a recent article : Digital Healthcare in 2017: Prepare for Good News
Disruption of the healthcare industry is at a level that many predicted but few understood. Yet, here we are facing 2017, with more amazing news. Moving to a more value-based model has meant greater focus on preventative medicine, patient-centered and patient-powered care, and reduced costs. Much of this is the result of new technologies within hospitals and surgery centers. But a great deal of it comes from wearables, remote monitoring, telemedicine, and a revolution in EHR — Electronic Health Records.

And for the francophone readers out there, this one is also interesting : SANTÉ : UNE RÉVOLUTION QUI VA AMÉLIORER NOS VIES TOUT EN ÉTANT MOINS CHER!
Croire que le domaine de la santé du fait de son mode de fortes relations humaines va pouvoir échapper au phénomène de la révolution numérique, c'est occulter les changements en marche : la machine de l'innovation disruptive a bel et bien démarré.

Florence Gaudry-Perkins


Let me talk about Biovision — February 13th 2017

Since the first Biovision in 1999, I had the privilege to participate each year to this forum and I can see today the positive evolution. The Biovision particularities are multiple.

  1. Lyon was chosen instead of Paris; this city is well known for it history in biomedical sciences: like vaccine industry with the family saga of Merieux; but also the place of animal health industry and also the famous P4 laboratory so useful for the research of emerging infectious diseases like Ebola, SARS and many others Lyon has also a very important university.
  2. Biovision since the beginning gave the opportunity of a strong networking, beyond the scientific cession the informal meetings outside the conference are frequent.
  3. Biovision has attracted many biotech companies from all around the world and mainly from Boston in the US.
  4. Each year the topics treated reflect the new trends in medecine and biology.

Biovision 2017 will tackle the main concerns science has to face


Every week Florence and I will come back on each topic to deepen the most important points.

Robert Sebbag